Sign In
Buy AXSM
$212.17
+1.13 (+0.535%)
At Close: Aug 04, 2026
Axsome (AXSM) Initiates Late-Stage Alzheimer's Agitation Study
01:33pm, Friday, 09'th Sep 2022
Axsome Therapeutics (AXSM) enrolls the first patient in a late-stage study of AXS-05 for Alzheimer's disease agitation.
Is Axsome Therapeutics a Buy?
10:53am, Friday, 09'th Sep 2022
Its near-term outlook is quite rosy, but there is also a risk it might not meet investors' hopes.
Why Is Axsome (AXSM) Up 26.9% Since Last Earnings Report?
03:30pm, Thursday, 08'th Sep 2022 Zacks Investment Research
Axsome (AXSM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Why Is Axsome (AXSM) Up 26.9% Since Last Earnings Report?
12:47pm, Thursday, 08'th Sep 2022
Axsome (AXSM) reported earnings 30 days ago. What's next for the stock?
Is SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now?
10:20am, Thursday, 08'th Sep 2022 Zacks Investment Research
Smart Beta ETF report for XPH
Mizuho Bolsters Price Target By 55% On This Migraine Stock
07:14pm, Wednesday, 07'th Sep 2022 Benzinga
Mizuho Securities assumes coverage of Axsome Therapeutics Inc (NASDAQ: AXSM), with a Buy rating and a price target of $76, representing a 25% upside from the last close is 55% above the initial pr
Axsome (AXSM) up 118.4% in the Past Three Months: Here's Why
12:02pm, Tuesday, 06'th Sep 2022
Axsome (AXSM) surges in the past three months owing to its Sunosi acquisition and promising progress on its pipeline candidate.
Nasdaq Bear Market: 2 Top Growth Stocks You'll Wish You'd Bought on the Dip
05:47am, Monday, 05'th Sep 2022
These stocks are poised for a strong rebound once the ongoing bear market turns bullish again.
Axsome (AXSM) Starts Late-Stage Study of Migraine Drug AXS-07
02:17pm, Friday, 02'nd Sep 2022
Axsome (AXSM) initiates a phase III open-label study for its pipeline candidate, AXS-07 for treating acute migraine.
15 Biotech Stocks That Hit Year Highs Over The Last Week, Including Sarepta, Axsome
01:47pm, Tuesday, 30'th Aug 2022
In recent days, biotech stocks have slowed their early-August sprint. But not all shares are ready to hit the showers.
10 Biotech Stocks Are Up 40% Or More This Year, Including Karuna, Axsome And Others
08:00am, Monday, 29'th Aug 2022
Biotech stocks are scorching right now. But the best of the best have strong gains.
3 Healthcare Stocks That Are Beating the Market
09:29am, Sunday, 28'th Aug 2022
Here's why our roundtable is bullish on Shockwave Medical, Axsome Therapeutics, and Rhythm Pharmaceuticals.
3 Growth Stocks Poised to Skyrocket
06:08am, Saturday, 27'th Aug 2022
All of them could have huge catalysts on the way.
This Growth Stock Is Soaring. Is It a Buy?
09:53am, Friday, 26'th Aug 2022
It may not be too late to get in on this drugmaker.
Why Axsome Therapeutics Stock Jumped This Week
02:48pm, Thursday, 25'th Aug 2022
Wall Street is optimistic about the company's newly approved depression medication.
